How has the wearable infusion pumps market evolved, and where is it heading next?
The wearable infusion pumps market size has grown strongly in recent years. It will grow from $1.37 $ billion in 2024 to $1.51 $ billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to the rising prevalence of chronic diseases, growing aging population, rising global healthcare spending, rising awareness and education, improvements in drug formulations.
The wearable infusion pumps market size is expected to see strong growth in the next few years. It will grow to $2.16 $ billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to a rise in chronic diseases, a growing global aging population, increasing patient preference for minimally invasive treatment options, development and enhancement of healthcare infrastructure in emerging markets. Major trends in the forecast period include integration of advanced technologies, development of smaller, more discreet devices, customizable infusion settings and dosage adjustments, enhanced data analytics.
Get Your Free Sample of The Global Wearable Infusion Pumps Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19756&type=smp
What are the key drivers behind the rapid expansion of the wearable infusion pumps market?
The increasing prevalence of chronic diseases is expected to propel the growth of the wearable infusion pump market going forward. Chronic diseases are long-term health conditions that usually progress slowly and persist for a year or more, often requiring ongoing medical attention. Some of the major chronic diseases include cancer, heart disease, diabetes, cancer, and arthritis. The prevalence of chronic diseases is rising due to factors such as a combination of genetic, environmental, and lifestyle factors, including poor diet, lack of exercise, and exposure to toxins. Wearable infusion pumps aid chronic disease patients by providing continuous, precise delivery of medications, enhancing adherence, and optimizing treatment. For instance, in June 2024, according to the National Health Service, a UK-based publicly funded healthcare system In England, 3,615,330 individuals were registered with a GP for non-diabetic hyperglycemia (pre-diabetes) in 2023, representing an 18% increase from 3,065,825 in 2022. This growth highlights a significant rise in pre-diabetes cases year-over-year. Therefore, the increasing prevalence of chronic diseases will drive the wearable infusion pump market.
What is the segmentation for the wearable infusion pumps market?
The wearable infusion pumpsmarket covered in this report is segmented –
1) By Type: Electronic Ambulatory Infusion Pumps, Patient-Controlled Analgesia (PCA) Pumps, Large Volume Pumps, Syringe Pumps, Other Types
2) By Usage: Disposable, Reusable
3) By Application: Diabetes, Antibiotic Infusion, Chemotherapy, Pain Management, Parkinson’s Disease, Other Applications
Subsegments:
1) Electronic Ambulatory Infusion Pumps: Portable Infusion Pumps, Implantable Infusion Pumps
2) Patient-Controlled Analgesia (PCA) Pumps: Continuous PCA Pumps, Demand PCA Pumps
3) Large Volume Pumps: Volumetric Pumps, Gravity Pumps
4) Syringe Pumps: Infusion Syringe Pumps, Ambulatory Syringe Pumps
5) Other Types: Insulin Pumps, Chemotherapy Pumps
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/wearable-infusion-pumps-global-market-report
Who are the most influential companies in the wearable infusion pumps market?
Major companies operating in the wearable infusion pumps market are Fresenius SE & Co. KGaA, Medtronic Plc, Medline Industries Inc., Becton Dickinson and Company, Baxter International Inc., B. Braun Melsungen AG, Nipro Corporation, ICU Medical Inc., Insulet Corporation, Sorenson Medical, Avanos Medical Inc., Vygon SA, pfm medical GmbH, Eitan Medical, Micrel Medical Devices SA, Zyno Medical LLC, Q-Core Medical Ltd., Epic Medical Solutions, MOOG Inc., Smiths Medical International Ltd
What are the most influential trends expected to drive the wearable infusion pumps market forward?
Major companies operating in the wearable infusion pump market are developing advanced products such as tubeless, wearable, and disposable insulin pumps to enhance user convenience, improve treatment adherence, and provide more efficient and discreet insulin delivery options for diabetes management. A tubeless, wearable, and disposable insulin pump is a small, skin-adhered device that offers continuous insulin delivery without external tubes and is replaced after a set period. For instance, in February 2023, GulfDrug LLC, a UAE-based healthcare company, launched EOPatch. This innovative product is a tubeless, wearable, and disposable insulin pump that can be controlled directly from Android and iOS smartphones using the Narsha app. The key features include up to 84 hours of continuous insulin delivery, simplifying the replacement cycle to twice a week, and the ability to communicate with certain blood glucose meters via Bluetooth. The Narsha app, the first smartphone application approved for this purpose, combines insulin delivery control and diabetes data management, eliminating the need for a separate controller.
What are the major regional insights for the wearable infusion pumps market, and which region holds the top position?
North America was the largest region in the wearable infusion pump market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the wearable infusion pumps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Wearable Infusion Pumps Market Report 2025 Offer?
The wearable infusion pumps market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
A wearable infusion pump is a portable medical device designed to deliver precise doses of medication or fluids over an extended period of time. It is typically worn on the body and provides continuous or intermittent infusion, offering convenience and flexibility for patients.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19756
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
